ArticleMolecular diversity2026
Novel oleanolic acid derivatives containing piperazine pyrimidine moieties: design, synthesis, and antimicrobial activity.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Natural products are main sources of new chemical entities for pesticide discovery and also important modification substrates for activity enhancement. In this study, a series of novel oleanolic acid derivatives containing piperazine pyrimidine structures were designed and synthesized. Multi NMR and high resolution-mass spectrometry technologies were utilized to characterize the synthesized compounds' structures. Antimicrobial potential of the title compounds was assessed against several phytopathogenic fungi and bacteria, namely Botryosphaeria dothidea, Fusarium sp. in morchella esculenta, Sclerotinia sclerotiorum, Fusarium graminearum, Rhizoctonia solani, Botrytis cinerea in strawberry, Botrytis cinerea in tobacco, Botrytis cinerea in blueberry, Alternaria solani, and Phomopsis sp., and Pseudomonas syringae pv. actinidiae, Xanthomonas oryzae pv. oryzicola, and Xanthomonas axonopodis pv. citri. The results showed that most of these compounds displayed good-to-moderate antimicrobial activities. Among them, compound 4e showed excellent efficacy against B. dothidea with EC
Indexed as
Identifiers
41288901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.